Trials / Unknown
UnknownNCT03633435
Home Hemodialysis Assisted by a Nurse for Arterio-venous Fistula Cannulation
Feasibility of a Home HD Program Assisted by a Nurse Coming at Home for Arterio-venous Fistula (AVF) Cannulation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Home HD (HHD) is associated with better outcome in end-stage renal disease patients compared to in-center HD, in particular in terms of quality of life. However fear of AVF cannulation is a known barrier for patient's choice and adoption of a HHD program. Providing nurse assistance for the cannulation can help developing HHD programs. The aim of this study is to evaluate the feasibility of assisted home hemodialysis, with the intervention of a nurse at home for arterio-venous fistula cannulation.
Detailed description
* Monocentric prospective interventional study. * Intervention is assisted HHD, defined as: rope-ladder cannulation at the patient's home provided by a trained private nurse at each dialysis session, and connection to the Nxstage System One * pilot study, with main objective defined as feasibility of the investigator's assisted HHD program. Pilot study usually concerns a small population, allowing us to develop thereafter a bigger study if the results are encouraging. * primary end-point criteria defined as definitive cessation of HHD with transfer to an other dialysis modality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | assisted home hemodialysis patients | Arteriovenous fistula cannulation at the patient's home provided by a trained private nurse at each dialysis session with the rope-ladder technique, and connection to the Nxstage System One |
Timeline
- Start date
- 2019-03-21
- Primary completion
- 2021-11-01
- Completion
- 2022-11-01
- First posted
- 2018-08-16
- Last updated
- 2021-02-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03633435. Inclusion in this directory is not an endorsement.